Related Experiment Video
Updated: Jun 23, 2025
05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.4K
Association Between Corticosteroid Dose and Pain Reduction After Sacroiliac Joint Injections
William J Naber1, Darin Scribner, Claire Z Kalpakjian
1From the Department of Physical Medicine and Rehabilitation, University of Michigan Health, Ann Arbor, Michigan (WJN, DS, CZK, RB).
American Journal of Physical Medicine & Rehabilitation
|June 25, 2024
Summary
Higher corticosteroid doses did not improve pain relief for sacroiliac joint injections. This study suggests lower doses may offer similar benefits for back pain, potentially reducing costs and side effects.
Area of Science:
- Pain Management
- Musculoskeletal Disorders
- Interventional Pain Procedures
Background:
- Sacroiliac joint pain is a common cause of back pain.
- Fluoroscopically guided corticosteroid injections are a recognized treatment.
- The optimal corticosteroid dosage for sacroiliac joint injections is not well-established.
Purpose of the Study:
- To investigate the relationship between corticosteroid dosage and pain relief.
- To compare pain outcomes following 40 mg versus 80 mg methylprednisolone injections.
- To inform future dosing guidelines for sacroiliac joint injections.
Main Methods:
- Retrospective analysis of 661 patients receiving sacroiliac joint injections.
- Comparison of 40 mg vs. 80 mg methylprednisolone doses.
- Linear regression modeling of pain score changes, controlling for covariates.
Main Results:
- Methylprednisolone dosage was not significantly associated with pain relief.
- Age and BMI were also not significantly associated with pain reduction.
- Female sex approached statistical significance, suggesting potentially less pain resolution.
Conclusions:
- Corticosteroid dose may not significantly impact pain relief in sacroiliac joint injections.
- Lower doses could reduce costs and potential side effects.
- Further research is needed to establish optimal dosing guidelines.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
614
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
614
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
428
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
428